Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/13/26 Johnson & Johnson (JNJ) Darzalex Faspro for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
6/13/26 Johnson & Johnson (JNJ) Talvey for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
6/12/26 Jazz Pharmaceuticals (JAZZ) Zepzelca for Small Cell Lung Cancer (SCLC) Subscribers Only Subscribers Only Subscribers Only
6/11/26 Caribou Biosciences (CRBU) vispacabtagene regedleucel for Diffuse Large B-Cell Lymphoma (DLBCL) Subscribers Only Subscribers Only Subscribers Only
6/11/26 Caribou Biosciences (CRBU) vispacabtagene regedleucel for Non-Hodgkin's Lymphoma (NHL) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/31/2023 Subscribers Only Subscribers Only Trial Announcement - Initiation
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update